This year’s PEGS in Boston glittered by excellent scientific contributions and discussions. Even though the felt number of attendees did not completely meet the records of the organisers – at least during the exhibition – it was great to be there.

New trends in protein engineering

The quality of exchanged information with the top-ranking scientific participants from academia and industry leaves no doubt about the value of this show. Some of the trends we picked up last week have been new insights in immunogenisity of biotherapeutics, the needs for more powerful bioanalytical methods during screening e.g. bi-specific antibodies in development and their ability of production screens in different cell lines. Very remarkably is the progress reported around cell free expression. This includes the tremendous advancements in terms of availability of an extremely high number of recombinant proteins within very short time at reasonable costs. It will be interesting to follow these developments also in the direction of production.

Current scientists needs

Along with these topics raised by several talks and during the poster sessions we recognised the need of scientists for new cutting edge targeting and application focused analytical instrumentations. The spectrum of the inquired solutions had been extremely wide but with an increasing trend in individual focused areas and less platform based.

Our conclusion

We at Biametrics say: thank you very much to all visitors at our booth and the great discussions we had with you! Thank you to the organisers, session chairs and all scientists. Thank you for the cool ideas to serve fresh popcorn in the exhibition area – although I am personally preferring sweet more than salty. We already booked our booth for next year and are very much looking forward to the in-between PEGS months to work with you on the success of your applications.

This article was written by
Günther is CEO and co-founder of Biametrics. He has a background in biology and holds a PhD in physical chemistry. He is one of the inventors of SCORE technology and always on the lookout for the next groundbreaking application of label-free microarrays.